Published

CVS Health Stock Jumps After Mixed Q3 Earnings, Takes $1.2 Billion Restructuring Charges Hit - CVS Health (NYSE:CVS)

Summary by Benzinga
CVS Health posted Q3 sales of $95.43 billion, driven by gains in Health Care Benefits. The company revised leadership roles and withdrew its 2024 guidance amid financial challenges.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 86% of the sources are Center
86% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)